C12N 2730/10122
New viral proteins or individual genes, new structural or functional aspects of
Official title: New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
C12N2730/10122 (New viral proteins or individual genes, new structural or functional aspects of) appears on 687 US grants and 590 published applications in this corpus.
Search patents in C12N- Granted patents
- 687
- Published applications
- 590
- Assignees
- 422
- Inventors
- 1,348
- Latest grant
- 18 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 2 | 0 |
| 1978 | 8 | 0 |
| 1979 | 4 | 0 |
| 1980 | 5 | 0 |
| 1981 | 1 | 0 |
| 1982 | 1 | 0 |
| 1983 | 3 | 0 |
| 1984 | 4 | 0 |
| 1985 | 6 | 0 |
| 1986 | 9 | 0 |
| 1987 | 12 | 0 |
| 1988 | 10 | 0 |
| 1989 | 20 | 0 |
| 1990 | 12 | 0 |
| 1991 | 15 | 0 |
| 1992 | 19 | 0 |
| 1993 | 11 | 0 |
| 1994 | 8 | 0 |
| 1995 | 7 | 0 |
| 1996 | 15 | 0 |
| 1997 | 19 | 0 |
| 1998 | 40 | 0 |
| 1999 | 25 | 0 |
| 2000 | 40 | 0 |
| 2001 | 26 | 3 |
| 2002 | 22 | 25 |
| 2003 | 23 | 61 |
| 2004 | 13 | 50 |
| 2005 | 11 | 23 |
| 2006 | 23 | 38 |
| 2007 | 16 | 32 |
| 2008 | 22 | 27 |
| 2009 | 17 | 28 |
| 2010 | 20 | 29 |
| 2011 | 27 | 31 |
| 2012 | 14 | 17 |
| 2013 | 14 | 16 |
| 2014 | 19 | 21 |
| 2015 | 7 | 17 |
| 2016 | 14 | 22 |
| 2017 | 9 | 14 |
| 2018 | 11 | 11 |
| 2019 | 12 | 15 |
| 2020 | 11 | 14 |
| 2021 | 8 | 21 |
| 2022 | 11 | 16 |
| 2023 | 10 | 18 |
| 2024 | 11 | 19 |
| 2025 | 13 | 12 |
| 2026 | 4 | 10 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Treatment of diseases related to hepatitis B virus18 Aug 2026US 12,709,634 B2Erasmus University Medical Center Rotterdam
- Hepadnavirus capsid protein heterodimers and virus-like particles28 Apr 2026US 12,612,433 B2The Trustees of Indiana University
- Adenoviral vectors encoding hepatitis B viral antigens fused to herpes virus glycoprotein D and methods of using the same21 Apr 2026US 12,605,444 B2The Wistar Institute
- HBV vaccine13 Jan 2026US 12,521,431 B2Oxford University Innovation Limited
- Therapeutic vaccine for hepatitis b virus (HBV) using the HBV core antigen16 Dec 2025US 12,496,339 B2Abacus Bioscience, Inc.
- Virus-like structured nano-connector and method thereof17 Sep 2026US 2026/0273077 A1Eye Hospital of Shandong First Medical University (Shandong Eye Hospital
- A Fusion Protein and a Particulate Antigen Containing the Same27 Aug 2026US 2026/0250328 A1Xiamen Innovax Biotech Co., Ltd.
- Hepatitis B Compositions23 Jul 2026US 2026/0207736 A1Glaxosmithkline Biologicals SA
- Dna vaccine composition comprising hepatitis virus b-derived mutant molecule and pathogen- or tumor-associated antigen molecule and use thereof23 Jul 2026US 2026/0209278 A1Seoul National University R&Db Foundation
- Compositions and methods for treating viral infections23 Jul 2026US 2026/0209279 A1G Tech Bio LLC
Most cited
By later US patents
- Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity737US 4,554,101 ANew York Blood Center, Inc. · 1985
- Method of identifying a stochastically-generated peptide, polypeptide, or protein having ligand binding property and compositions thereof519US 5,723,323 A1998
- Process for the production of stochastically-generated transcription or translation products347US 5,814,476 A1998
- Process for the production of expression vectors comprising at least one stochastic sequence of polynucleotides330US 5,824,514 A1998
- Process for the production of stochastically-generated peptides,polypeptides or proteins having a predetermined property317US 5,817,483 A1998